EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Presentation and Outcomes of Lassa Fever in Children in Nigeria: A Prospective Cohort Study (LASCOPE)

Alexandre Duvignaud iD, Ijeoma C Etafo, Marie Jaspard, Qasim Salau, Béatrice Serra, Abiodun J Kareem, Sylvain Juchet, Tolulope O Jegede, Delphine Gabillard, Abiodun T Abidoye, Camille Le Gal, Chukwuyem Abejegah und 19 weitere

Journal of the Pediatric Infectious Diseases Society · 2024

DOI: 10.1093/jpids/piae083 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2024. Verfasst von Alexandre Duvignaud und 30 weiteren Autor:innen. Beteiligte Einrichtung: Global Health in the Global South Research Team-University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, French …. Hauptthemen laut MEDLINE: Lassa Fever, Ribavirin, Antiviral Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Data on the presentation, management, and outcomes of Lassa fever (LF) in children are limited.

Methods

Description of the clinical and biological features, treatment, and outcomes of reverse transcriptase and polymerase chain reaction (RT-PCR)-confirmed LF in children aged under 15, enrolled in the LASsa fever clinical COurse and Prognostic factors in an Epidemic context (LASCOPE) prospective cohort study in Nigeria between April 2018 and February 2023.

Results

One hundred twenty-four children (aged under 12 months: 19; over 12 months: 105) were hospitalized with RT-PCR-confirmed LF. All received intravenous ribavirin. During follow-up, 99/124 (80%) had fever; 71/124 (57%) had digestive symptoms, vomiting (n = 56/122, 46%) and abdominal pain (n = 34/78 aged ≥5 years, 44%) more often than diarrhea (n = 19/124, 15%); 17/124 (14%) had hemorrhagic signs; 44/112 (39%) had a hematocrit lower than 25%, of whom 32/44 (73%) received transfusions; 44/88 (50%) developed hypotension; 18/112 (16.1%) developed kidney disease improving global outcome (KDIGO) ≥2 acute kidney injury; 10/112 (8.9%) had KDIGO 3 acute kidney failure; 4/124 (3.2%) underwent renal replacement therapy. Seven children died, including 4 aged under 12 months (case fatality rate: under 12 months—22%, 95% confidence interval (CI): 7%–48%; over 12 months—2.9%, 95% CI: 0.7%–8.7%). In univariable analysis, age (P = .003), impaired consciousness (P = .026), and Lassa RT-PCR Ct value (P = .006) were associated with Day 30 mortality.

Conclusions

The fatality rate for children over 12 months hospitalized with LF was lower than that previously reported for adults. Hypotension and acute kidney injury were the most frequent organ dysfunctions. Bleeding was relatively infrequent. Anemia and the need for transfusion were common, the relative contribution of ribavirin-induced hemolysis being unknown.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lassa FeverRibavirinAntiviral AgentsHumansNigeriaProspective StudiesMaleFemaleChild, PreschoolChildInfantAdolescentHospitalizationLassa virusAcute Kidney Injury

Stichwörter der Autor:innen

Lassa feverNigeriaacute kidney injuryanemiachildrenprognosis

Substanzen

RibavirinAntiviral Agents

Autor:innen und Institutionen

  • Global Health in the Global South Research Team-University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, French Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux…
  • Department of Infectious Diseases and Tropical Medicine, Division of Tropical Medicine and Clinical International Health, CHU Bordeaux, Hôpital Pellegrin, Place Amélie Raba Léon, Bordeaux, France.
  • Programme PAC-CI/ANRS Research Site, University Hospital Centre of Treichville, Abidjan, Côte d'Ivoire.
  • The Alliance for International Medical Action, Dakar, Senegal.
  • Lassa Fever Response Team, Infection Control and Research Centre, Federal Medical Centre Owo, Owo, Nigeria.
  • Department of Infectious Diseases and Tropical Medicine, Hôpital Saint Antoine, Assistance Publique Hôpitaux de Paris, Paris, France.

ORCID-Profile: Alexandre Duvignaud

Zitieren

APA

Duvignaud, A., Etafo, I. C., Jaspard, M., Salau, Q., Serra, B., Kareem, A. J., Juchet, S., Jegede, T. O., Gabillard, D., Abidoye, A. T., Le Gal, C., Abejegah, C., Owhin, S., Okwaraeke, K., Doutchi, M., Katembo Vihundira, J., Besong-Lache, R. M., Seri, B., Bérerd-Camara, M., …, & Ayodeji, O. O. (2024). Presentation and Outcomes of Lassa Fever in Children in Nigeria: A Prospective Cohort Study (LASCOPE). Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piae083

Vancouver

Duvignaud A, Etafo IC, Jaspard M, Salau Q, Serra B, Kareem AJ, et al. Presentation and Outcomes of Lassa Fever in Children in Nigeria: A Prospective Cohort Study (LASCOPE). Journal of the Pediatric Infectious Diseases Society. 2024. doi:10.1093/jpids/piae083

BibTeX
@article{Duvignaud2024,
  author = {Duvignaud, Alexandre and Etafo, Ijeoma C and Jaspard, Marie and Salau, Qasim and Serra, Béatrice and Kareem, Abiodun J and Juchet, Sylvain and Jegede, Tolulope O and Gabillard, Delphine and Abidoye, Abiodun T and Le Gal, Camille and Abejegah, Chukwuyem and Owhin, Sampson and Okwaraeke, Kevin and Doutchi, Mahamadou and Katembo Vihundira, Jackson and Besong-Lache, Rene-M and Seri, Benjamin and Bérerd-Camara, Marion and Salam, Alex P A and Olayinka, Adebola and Horby, Peter and Ogbaini-Emovon, Ephraim and Duraffour, Sophie and Ahmed, Liasu A and Günther, Stephan and Adedosu, Akinola N and Anglaret, Xavier and Malvy, Denis and Lang, Hans J and Ayodeji, Oladele O},
  title = {Presentation and Outcomes of Lassa Fever in Children in Nigeria: A Prospective Cohort Study (LASCOPE)},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2024},
  doi = {10.1093/jpids/piae083}
}
Kostenlos starten →